QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Linda Karlsson at conference
Linda Karlsson attended the conference ”Registry-based research in Sweden – past, present and future” organised by the Unit of Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet. For more information regarding register-based research in Sweden see simsam.nu.
Anders Gustavsson published in Pain Medicine.
Anders Gustavsson has co-authored an article on treatment patterns in neuropathic pain, published in Pain Medicine.
Pubmed link
Fredrik Borgström co-authors article in Value in Health
Fredrik Borgström has co-authored an article in Value in Health that compared the cost-effectiveness of biologic treatments for rheumatoid arthritis based on clinical trial data versus data from the Swedish RA registry. Pubmed link
Fredrik Borgström and Oskar Ström published in Osteoporosis International
The first publication based on the International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) co-authored by Fredrik Borgström and Oskar Ström has been published in Osteoporosis International. The ICUROS prospectively collects data on costs and quality of life over a period of 18 months after fractures in 11 countries. This manuscript presents the quality of life during the first 4 months after fracture. Pubmed link